HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Madeleine Duvic Selected Research

Inflammation (Inflammations)

3/2014Dermatologic toxicities to targeted cancer therapy: shared clinical and histologic adverse skin reactions.
2/2008Inflammation resolved by retinoid X receptor-mediated inactivation of leukotriene signaling pathways.
12/2006Abnormal expression of interleukin-23 in mycosis fungoides/Sézary syndrome lesions.
8/2004Severe radiation dermatitis is related to Staphylococcus aureus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Madeleine Duvic Research Topics

Disease

97Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
01/2023 - 01/2002
73Mycosis Fungoides
02/2024 - 01/2002
73Neoplasms (Cancer)
12/2023 - 03/2002
21Lymphoma (Lymphomas)
11/2023 - 09/2003
17Melanoma (Melanoma, Malignant)
04/2016 - 04/2003
13T-Cell Lymphoma (Lymphoma, T Cell)
11/2023 - 01/2004
10Disease Progression
10/2022 - 07/2007
9Psoriasis (Pustulosis Palmaris et Plantaris)
01/2019 - 10/2003
9Hematologic Neoplasms (Hematological Malignancy)
03/2017 - 07/2007
9Fatigue
11/2015 - 02/2004
8Infections
12/2023 - 11/2002
8Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
10/2022 - 01/2002
8Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2014 - 01/2007
7Primary Cutaneous Anaplastic Large Cell Lymphoma
12/2021 - 10/2009
7Lymphomatoid Papulosis
02/2019 - 01/2003
6Fever (Fevers)
05/2022 - 02/2004
6Pruritus (Itching)
12/2021 - 03/2002
6Sezary Syndrome (Sezary Erythroderma)
01/2021 - 01/2002
6Lymphoproliferative Disorders (Lymphoproliferative Disorder)
02/2019 - 12/2005
6Thrombocytopenia (Thrombopenia)
01/2019 - 02/2004
6Leukemia
01/2019 - 11/2002
6Alopecia Areata
10/2018 - 02/2002
5Skin Neoplasms (Skin Cancer)
09/2014 - 12/2005
5Exanthema (Rash)
03/2014 - 12/2005
4Actinic Keratosis
05/2019 - 12/2010
4Basal Cell Carcinoma (Rodent Ulcer)
05/2019 - 10/2003
4Hypertriglyceridemia
09/2017 - 11/2002
4Skin Diseases (Skin Disease)
01/2017 - 02/2008
4Keratoacanthoma
07/2014 - 02/2013
4Inflammation (Inflammations)
03/2014 - 08/2004
4Erythema
02/2009 - 08/2003
3Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2022 - 09/2003
3Peripheral Nervous System Diseases (PNS Diseases)
12/2021 - 01/2017
3Pain (Aches)
12/2021 - 11/2006
3Sepsis (Septicemia)
01/2018 - 11/2012
3Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
12/2016 - 04/2009
3B-Cell Lymphoma (Lymphoma, B Cell)
11/2016 - 01/2014
3Nevus (Nevi)
04/2016 - 08/2009
3Graft vs Host Disease (Graft-Versus-Host Disease)
08/2013 - 01/2002
3Carcinogenesis
11/2008 - 12/2003
3T-Cell Leukemia (Leukemia, T Cell)
03/2008 - 07/2004
2Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
10/2022 - 01/2021
2Pseudolymphoma
01/2022 - 04/2003
2Dermatitis
11/2019 - 08/2004
2Rheumatoid Arthritis
01/2019 - 01/2006
2Edema (Dropsy)
01/2019 - 12/2005

Drug/Important Bio-Agent (IBA)

20Bexarotene (LGD1069)FDA Link
12/2021 - 03/2002
15denileukin diftitox (Ontak)FDA Link
11/2017 - 01/2002
12Histone Deacetylase InhibitorsIBA
02/2016 - 11/2005
11Brentuximab VedotinIBA
11/2023 - 11/2015
11VorinostatFDA Link
01/2021 - 11/2005
10RetinoidsIBA
02/2009 - 11/2002
9Proteins (Proteins, Gene)FDA Link
02/2024 - 01/2002
7mogamulizumabIBA
01/2022 - 03/2015
7SteroidsIBA
01/2019 - 03/2003
7Biomarkers (Surrogate Marker)IBA
01/2018 - 10/2003
6Methotrexate (Mexate)FDA LinkGeneric
12/2021 - 05/2010
6Anti-Bacterial Agents (Antibiotics)IBA
05/2020 - 08/2004
6romidepsin (FK228)FDA Link
01/2018 - 10/2010
6AntigensIBA
04/2017 - 12/2002
6Histone Deacetylases (Histone Deacetylase)IBA
03/2017 - 11/2005
5Monoclonal AntibodiesIBA
01/2021 - 08/2004
5Mechlorethamine (Nitrogen Mustard)FDA Link
01/2015 - 03/2003
5InterferonsIBA
10/2014 - 01/2003
5VemurafenibIBA
07/2014 - 01/2013
4CytokinesIBA
11/2023 - 08/2004
4T-Cell Antigen Receptors (T-Cell Receptor)IBA
10/2018 - 12/2014
410-propargyl-10-deazaaminopterinFDA Link
07/2017 - 03/2008
4LigandsIBA
02/2017 - 07/2010
4Isotretinoin (Accutane)FDA LinkGeneric
09/2006 - 01/2003
3Immunoconjugates (Immunoconjugate)IBA
11/2023 - 02/2019
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2023 - 04/2003
3IntegrinsIBA
09/2019 - 03/2011
3Lenalidomide (CC 5013)FDA Link
01/2019 - 04/2008
3MutagensIBA
04/2016 - 12/2005
3L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2016 - 03/2009
3Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
02/2009 - 01/2003
3tazarotene (Tazorac)FDA Link
02/2009 - 10/2003
3Messenger RNA (mRNA)IBA
11/2008 - 10/2003
3GemcitabineFDA Link
02/2007 - 07/2006
3Tretinoin (Retinoic Acid)FDA LinkGeneric
09/2006 - 01/2003
2Glia Maturation Factor (GMF)IBA
02/2024 - 09/2016
2VaccinesIBA
12/2023 - 11/2008
2dupilumabIBA
01/2023 - 01/2022
2hypericinIBA
01/2022 - 12/2010
2pembrolizumabIBA
01/2020 - 01/2019
2Immune Checkpoint InhibitorsIBA
01/2020 - 11/2019
2Interleukin-1 (Interleukin 1)IBA
09/2019 - 05/2019
2Imiquimod (Aldara)FDA LinkGeneric
05/2019 - 09/2017
2Alanine Transaminase (SGPT)IBA
01/2019 - 11/2006
2MicroRNAs (MicroRNA)IBA
11/2018 - 01/2016
2MucinsIBA
05/2018 - 01/2003

Therapy/Procedure

90Therapeutics
01/2023 - 01/2002
16Drug Therapy (Chemotherapy)
05/2021 - 02/2003
13Radiotherapy
11/2023 - 01/2003
12Photopheresis
03/2022 - 01/2002
5Aftercare (After-Treatment)
10/2020 - 01/2006
3Photochemotherapy (Photodynamic Therapy)
01/2022 - 01/2010
3Stem Cell Transplantation
10/2016 - 01/2006
2Intravenous Infusions
01/2019 - 06/2015